Quick Answer
Scinai Immunotherapeutics Ltd. reported Net Income Loss of $4.80 million for the year ending 2024.
- Scinai Immunotherapeutics Ltd. showed an increase of +173.8% in Net Income Loss from 2023 to 2024.
- This data is from Scinai Immunotherapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on May 7, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2021 to 2024), Scinai Immunotherapeutics Ltd.'s Net Income Loss has grown by 158.4%.
- Historical annual values: Fiscal year 2024: $4.80 million | Fiscal year 2023: -$6.50 million | Fiscal year 2022: -$5.80 million | Fiscal year 2021: -$8.21 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: